Prognostic value of pretreatment temporal muscle thickness after curative surgery for oral cavity squamous cell carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
    • Publication Information:
      Publication: 1998- : Tokyo : Springer-Verlag Tokyo
      Original Publication: Tokyo : Published for the Japan Society of Clinical Oncology by Churchill Livingstone, c1996-
    • Subject Terms:
      Mouth Neoplasms*/surgery ; Mouth Neoplasms*/pathology ; Carcinoma, Squamous Cell*/surgery ; Carcinoma, Squamous Cell*/pathology ; Sarcopenia*/pathology ; Sarcopenia*/diagnostic imaging ; Temporal Muscle*/pathology ; Temporal Muscle*/diagnostic imaging; Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Adult ; Aged, 80 and over ; Tomography, X-Ray Computed ; Retrospective Studies
    • Abstract:
      Background: Sarcopenia is a poor prognostic factor in various diseases. Temporal muscle thickness (TMT) has been reported to be associated with sarcopenia. We investigated the prognostic value of TMT in patients with oral squamous cell carcinoma.
      Methods: This study included 61 patients with oral squamous cell carcinoma. Two board-certified otolaryngologists measured TMT based on pre-treatment CT. The following sex-specific TMT cut-off values were used in accordance with previous reports: ≤ 6.3 mm in men, and ≤ 5.2 mm in women. We classified patients into normal TMT group and low TMT group according to the cutoff values. The correlation between the TMT measurements of the two readers was tested using the interclass correlation coefficient (ICC). Cox regression models were used to verify the association between TMT and prognostic factors.
      Results: The low TMT group had a significantly lower BMI than the normal TMT group. Patients with low TMT at baseline had a significantly higher risk of death than those with normal TMT (hazard ratio 4.51; 95% confidence interval [CI] 1.49-13.61; p = 0.0076). There were no significant differences in disease-specific survival between the two groups. The correlation between the two evaluators' TMT measurements was excellent (ICC 0.988, 95% CI 0.981-0.933).
      Conclusions: Sex-specific TMT was associated with overall survival in patients with oral squamous cell carcinoma. TMT is easy to assess and its measurement is consistent between evaluators.
      (© 2024. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.)
    • References:
      Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300–307. (PMID: 10.1016/j.jamda.2019.12.01232033882)
      von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1:129–133. (PMID: 10.1007/s13539-010-0014-2)
      Du E, Mazul AL, Farquhar D et al (2019) Long-term survival in head and neck cancer: impact of site, stage, smoking, and Human Papillomavirus status. Laryngoscope 129:2506–2513. (PMID: 10.1002/lary.27807306377626907689)
      Terazawa K, Ohashi T, Shibata H et al (2022) Immune-modified Glasgow prognostic score: a new prognostic marker for head and neck cancer. Head Neck 44:2555–2563. (PMID: 10.1002/hed.2717036054630)
      Cho Y, Kim JW, Keum KC et al (2018) Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy. Front Oncol 8:457. (PMID: 10.3389/fonc.2018.00457304601946232888)
      Chargi N, Bril SI, Emmelot-Vonk MH et al (2019) Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhinolaryngol 276:1475–1486. (PMID: 10.1007/s00405-019-05361-4308303006458984)
      Thomas CM, Sklar MC, Su J et al (2019) Evaluation of older age and frailty as factors associated with depression and postoperative decision regret in patients undergoing major head and neck surgery. JAMA Otolaryngol Head Neck Surg 145:1170–1178. (PMID: 10.1001/jamaoto.2019.3020316218126802425)
      van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM et al (2020) Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol 147:103–110. (PMID: 10.1016/j.radonc.2020.03.01432251949)
      Orzell S, Verhaaren BFJ, Grewal R et al (2022) Evaluation of sarcopenia in older patients undergoing head and neck cancer surgery. Laryngoscope 132:356–363. (PMID: 10.1002/lary.2978234383321)
      Yoshimura T, Suzuki H, Takayama H et al (2021) Prognostic role of preoperative sarcopenia evaluation of cervical muscles with long-term outcomes of patients with oral squamous cell carcinoma. Cancers (Basel) 13:4725. (PMID: 10.3390/cancers1318472534572952)
      Hasegawa Y, Yoshida M, Sato A et al (2019) Temporal muscle thickness as a new indicator of nutritional status in older individuals. Geriatr Gerontol Int 19:135–140. (PMID: 10.1111/ggi.1357030689287)
      Leitner J, Pelster S, Schöpf V et al (2018) High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases. PLoS ONE 13:e0207849. (PMID: 10.1371/journal.pone.0207849304963076264824)
      Steindl A, Leitner J, Schwarz M et al (2020) Sarcopenia in neurological patients: standard values for temporal muscle thickness and muscle strength evaluation. J Clin Med 9:1272. (PMID: 10.3390/jcm9051272323540037288067)
      Hasegawa Y, Yoshida M, Sato A et al (2021) A change in temporal muscle thickness is correlated with past energy adequacy in bedridden older adults: a prospective cohort study. BMC Geriatr 21:182. (PMID: 10.1186/s12877-021-02086-0337221957962248)
      Nozoe M, Kubo H, Kanai M et al (2021) Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke. Clin Neurol Neurosurg 201:106444. (PMID: 10.1016/j.clineuro.2020.10644433395619)
      Furtner J, Weller M, Weber M et al (2022) Temporal muscle thickness as a prognostic marker in patients with newly diagnosed glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071–22072 and CORE trials. Clin Cancer Res 28:129–136. (PMID: 10.1158/1078-0432.CCR-21-198734667022)
      Katsuki M, Kakizawa Y, Nishikawa A et al (2021) Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping. Surg Neurol Int 12:151. (PMID: 10.25259/SNI_814_2020339483218088495)
      World Health Organization (2000) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva, Switzerland.
      Furtner J, Berghoff AS, Albtoush OM et al (2017) Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases. Eur Radiol 27:3167–3173. (PMID: 10.1007/s00330-016-4707-6280506945491578)
      Kang Y, Lee JW, Koh YH et al (2011) New MRI grading system for the cervical canal stenosis. AJR Am J Roentgenol 197:W134–W140. (PMID: 10.2214/AJR.10.556021700974)
      Boeun L, Bae YJ, Jeong WJ et al (2021) Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma. Sci Rep 11:19717. (PMID: 10.1038/s41598-021-99201-3)
      Kanda Y (2013) Investigation of the freely available essy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458. (PMID: 10.1038/bmt.2012.24423208313)
      Furtner J, Berghoff AS, Schöpf V et al (2018) Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases. J Neurooncol 140:173–178. (PMID: 10.1007/s11060-018-2948-8300081546182383)
      Xiaoming Z, Xiaohua X, Qingli D et al (2019) Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr 19(1):183. (PMID: 10.1186/s12877-019-1195-y)
      Kara E, Şahutoğlu T, Demirbaş S (1992) Beyazal M (2022) Temporal muscle thickness predicts mortality in prevalent hemodialysis patients. Rev Assoc Med Bras 68:1715–1720. (PMID: 10.1590/1806-9282.20220844)
      Zanoni DK, Montero PH, Migliacci JC et al (2019) Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol 90:115–121. (PMID: 10.1016/j.oraloncology.2019.02.001308461696417804)
    • Contributed Indexing:
      Keywords: Oral squamous cell carcinoma; Prognostic factors; Sarcopenia; Temporal muscle thickness
    • Publication Date:
      Date Created: 20240730 Date Completed: 20240923 Latest Revision: 20240923
    • Publication Date:
      20240923
    • Accession Number:
      10.1007/s10147-024-02591-3
    • Accession Number:
      39080115